Application of α-lipoic acid beyond peripheral diabetic polyneuropathy (a report of 3 cases)

Medical Journal of Indonesia

Volumn 20, Issue 2, 2011, Pages 143-148

  Freisleben, Hans Joachim ^a   Tandian, David ^b   Kuebel Thiel, Krista ^c  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^c NONE   (Germany)

Author keywords

Cancer therapy; Cerebral trauma; Infection; Inflammation; Neuropathy; Lipoic acid

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; CALCIUM; CARBAMAZEPINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; DOXYCYCLINE; EPERISONE; ISOSORBIDE DINITRATE; LEVOTHYROXINE; PACLITAXEL; RANITIDINE; SELENIUM; SIMVASTATIN; SPIRONOLACTONE; TEGASEROD; THIOCTIC ACID; TOLTERODINE; VITAMIN D;

ADULT; AGED; ARTICLE; BACTERIAL ARTHRITIS; BORRELIA INFECTION; BRAIN HEMATOMA; BRAIN INJURY; BREAST CANCER; CANCER THERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC NEUROPATHY; DYSARTHRIA; ENZYME THERAPY; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; MALE; MIDDLE AGED; MORNING DOSAGE; MOTOR DYSFUNCTION; MULTIPLE CYCLE TREATMENT; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; PARESTHESIA; PERIPHERAL NEUROPATHY; PHYSIOTHERAPY; PNEUMONIA; POLYNEUROPATHY; SENSORY DYSFUNCTION; SINGLE DRUG DOSE; SUBDURAL HEMATOMA; TICK BORNE DISEASE; TOXOPLASMOSIS; VITAMIN SUPPLEMENTATION; WALKING DIFFICULTY;

EID: 85008684111     PISSN: 08531773     EISSN: 22528083     Source Type: Journal    
DOI: 10.13181/mji.v20i2.438     Document Type: Article

References (22)

1. Suzuki YJ, Tsuchiya M, Packer L. Thioctic acid and dehydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Rad Res Commun. 1991;15:255-63.
2. Han D, Handelman GJ, Packer L. Analysis of reduced and oxidized lipoic acid in biological samples by high-performance liquid chromatography. Methods Enzymol. 1995; 251:315-25.
3. Handelman GJ, Han D, Tritschler H, Packer L. a-Lipoic acid reduction by mammalian cells to the dithiol form, and released into the culture medium. Biochem Pharmacol. 1994;47:1725-30.
4. Haramaki N, Handelman GJ. Tissue-specific pathways of a-lipoic acid reduction in mammalian systems. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic Acid in Health and Disease. NewYork: M Dekker, Inc.; 1997. p. 145-62.
5. Gascoigne IM, Radda GK. The chemistry of flavins and flavoproteins. III. The reaction of dihydrolipoic acid with flavins. Biochim Biophys Acta. 1967;131:498-507.
6. Jocelyn PC. Biochemistry of the -SH group. London, New York: Academic Press; 1972.
7. Searls RL, Sanadi DR. a-Ketoglutarate dehydrogenase. VIII. Isolation and some properties of a flavoprotein component. J Biol Chem. 1980;235:2485-91.
8. Roldan EJ, Kerzberg EM, Boveris A. Kinetics of chemoluminescence of rat intestine during ischemia and reperfusion. Medicina (Buenos Aires) 1989;49:336-40.
9. Freisleben HJ, Kagan VE, Packer L. Recycling of antioxidants in LDL. A novel approach to antiatherogenesis. In: Book of Abstracts of the 1st International Conference of Pathophysiology (ISP/SFFR) Moscow: 1991. p. 228-9.
10. Kagan VE, Freisleben HJ, Tsuchia M, Forte T, Packer L. Generation of probucol radicals and their reduction by ascorbate and dihydrolipoic acid in human low density lipoproteins. Free Rad Res Comm. 1991;15:265-76.
11. Hyslop PA, Hinshaw DR, Halsey WA Jr, Schraufstätter IV, Sauerheber RD, Spragg RG et al. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem. 1988;263:1665-75.
12. Hermann R, Niebch G. Human pharmacokinetics of a-lipoic acid. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic Acid in Health and Disease. New York: M Dekker, Inc. 1997. P 337-60.
13. Freisleben HJ, Fuchs J, Mainka L, Zimmer G. Reactivity of mitochondrial sulfhydryl groups towards dithionitrobenzoic acid and bromobimanes under oligomycin-inhibited and uncoupling conditions. Arch Biochem Biophys. 1988;266: 89-97.
14. Bittl JA, Ingwall JS. Reaction rates of creatine kinase and ATP synthesis in the isolated rat heart. A 31P NMR magnetization transfer study. J Biol Chem. 1985;260: 3512-17.
15. Freisleben HJ, Zimmer G. Mitochondrial F1Fo ATPase in hypoxia. Comparison of two differently isolated complexes in presence of dihydrolipoic acid. In: Benzi G, editor. Advances in Myochemistry Vol.2. London, Paris: J. Libbey Ltd; 1989. p.51-2.
16. Freisleben HJ. Lipoic acid reduces ischemia-reperfusion injury in animal models. Toxicology. 2000;148:159-71.
17. Freisleben HJ, Neeb A, Lehr F, Ackermann H. Influence of selegiline and lipoic acid on the life expectancy of immunosuppressed mice. Arzneim Forsch/Drug Res. 1997;47(1):776-80.
18. Haak E, Usadel KH, Kusterer K, Amini P, Frommeyer R, Tritschler HJ, Haak T. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic polyneuropathy. Experimental and Clinical Endocrinology and Diabetes. 2000;108: 168-74.
19. nd International Thioctic Acid – Workshop: The Role of the Redox System Alpha-Lipoic Acid/Dihydrolipoic Acid in Organ-Specific Models of Impaired Oxygen Supply. Frankfurt/Main: Universimed-Verlag. ISBN 3-89143-018-3. 1992. p.89-102.
20. Wolz P, Krieglstein J. Neuroprotective activity of lipoic and dihydro-lipoic acid. In: Fuchs J, Packer L, Zimmer G, editors. Lipoic Acid in Health and Disease. New York: M Dekker, Inc; 1997. p.205-25.
21. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant α-lipoic acid. Free Radic. Biol. Med. 1997;22:359-78.
22. Hall ED, Vaishnav RA, Mustafa AG. Antioxidant Therapies for Traumatic Brain Injury. Neurotherapeutics. 2010;7:51-61.